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Standard automated perimetryDetecting glaucomatous progression is an important aspect of glaucoma management. The assessment of
longitudinal series of visual fields, measured using Standard Automated Perimetry (SAP), is considered
the reference standard for this effort. We seek efficient techniques for determining progression from lon-
gitudinal visual fields by formulating the problem as an optimization framework, learned from a popu-
lation of glaucoma data. The longitudinal data from each patient’s eye were used in a convex
optimization framework to find a vector that is representative of the progression direction of the sample
population, as a whole. Post-hoc analysis of longitudinal visual fields across the derived vector led to opti-
mal progression (change) detection. The proposed method was compared to recently described progres-
sion detection methods and to linear regression of instrument-defined global indices, and showed
slightly higher sensitivities at the highest specificities than other methods (a clinically desirable result).
The proposed approach is simpler, faster, and more efficient for detecting glaucomatous changes, com-
pared to our previously proposed machine learning-based methods, although it provides somewhat less
information. This approach has potential application in glaucoma clinics for patient monitoring and in
research centers for classification of study participants.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Glaucoma, a group of optic neuropathies, is one of the two lead-
ing causes of preventable blindness and affects more than 60 mil-
lion individuals worldwide [1,2]. Glaucoma causes morphological
changes of the optic disk accompanied by visual field damage that
is slowly progressing, with a time course of several years. The
patient often is not aware of visual field loss in the early stages
of the disease [1,2]. Detecting structural and functional changes
associated with glaucoma is important to the physician who must
decide whether the current therapy is preventing the progression
of the disease or whether some more invasive treatment (e.g., sur-
gery) is necessary. Determining whether visual field defects have
progressed in individual patients remains one of the most chal-
lenging aspects of glaucoma management.Standard Automated Perimetry (SAP) is an established visual
function test for identifying glaucoma and assessing its severity.
Current SAP software measures the retinal sensitivity to light at
52 different test points (for 24-2 stimuli, with a visible range from
0 dB to approximately 40 dB) as projected onto the retina from the
visual field. Status of test locations (e.g., within normal limits or
outside of normal limits) is determined by statistical comparison
with the instrument’s normative database composed of age nor-
malized SAP results [3]. Fig. 1 shows how the visual field is col-
lected from the instrument and a sample visual field test and
data vector (52-dimensional). To detect change, i.e., glaucomatous
progression, eye experts subjectively monitor a sequence of SAP
tests. This subjectivity often results in biased or inconsistent deci-
sions [4]. We seek to make the process more objective. Computa-
tional methods are desirable because these methods produce
objective outcomes and overcome potentially biased or inconsis-
tent strategies.
Several methods have been developed to identify change in
glaucomatous visual fields over time. Some of these methods are
Fig. 1. SAP visual field collection, a sample pattern, and data vector.
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baseline examinations, with an event, e.g., progression or no pro-
gression, assigned if change is greater than predetermined criteria)
and some are trend-based (in which the rate of change is estimated
based on regression analysis of a sequence of visual field examina-
tions). Because the currently proposed method is trend-based, we
describe seven other trend-based methods. (1) Ordinary least
square regression (OLSR) of the commercially available SAP soft-
ware parameters mean deviation (MD), that reflects global change
(whereas glaucoma changes often are localized) [5] and (2) OLSR of
Visual Field Index (VFI) that is calculated based on a weighted dis-
tribution of values from each visual field point and hence is corre-
lated with patient visual function [6,7]. Both methods one and two
are based on instrument-generated global indices.
(3) Point-wise linear regression (PLR), that tracks change at
each individual visual field location over the entire follow-up dura-
tion. For PLR, progression is arbitrarily defined based on a fixed
number of changing test locations. PLR is calculated in the com-
mercially available Progressor software [8]. PLR does not provide
a strictly defined significance value for the severity of deterioration
of the whole visual field, which makes it difficult to interpret [9].
(4) Permutation Analysis of PLR (PoPLR) is an individualized anal-
ysis that uses a p value combination function and permutation
analysis to detect glaucomatous change [9]. PoPLR requires a base-
line exam and at least six independent sequential follow-up exams
to generate greater than 1000 permutations, required to calculate a
robust rate of change estimate. The application of PLR and PoPLR to
other glaucoma-related measurements (e.g., retinal nerve fiber
layer thickness measurement) has not yet been reported. Both
PLR and PoPLR are individualized methods; the decision regarding
progression is made based on individual patient data and not based
on population data.
(5) Analysis with Non-Stationary Weibull Error Regression and
Spatial Enhancement (ANSWERS), relies on a mixture of Weibull
distributions to model visual field variability and a Bayesian
method to aggregate the spatial correlation of local measurements
to confirm repeatable defects in the same or adjacent locations in
follow-up examinations [10]. ANSWERS was designed specifically
to detect progression in SAP visual fields. The application of
ANSWERS to other glaucoma-related measurements has not yet
been reported.
Recent advances in machine learning techniques provide new
approaches for glaucoma-related diagnosis and progression detec-
tion based on learning from a pool of data [11–15]. (6) Variational
Bayesian independent component analysis mixture model (VIM)
for glaucoma defect pattern identification and progression detec-
tion is a machine learning classification-based approach developed
by our group [16–18]. (7) Gaussian Mixture Model with Expecta-tion Maximization (GEM), another machine learning-based
approach, recently was introduced by our group and was success-
fully applied to visual field data to identify glaucoma-related defect
patterns and to detect progression [19]. The initial creation of an
environment using these machine learning approaches for progres-
sion detection is computationally and algorithmically complex.
All of the above methods are trend-based approaches. Methods
one and two also provide the rate of progression, while methods
three to seven simply indicate whether the eye is progressing
without any information on the rate of progression.
Guided Progression Analysis (GPA), an instrument-generated
parameter, is an example of an event-based analysis [20]. GPA ana-
lyzes the test point by test point pattern deviation of a sequence of
visual fields to identify glaucomatous progression. GPA requires
two baseline and three follow-up exams to assign a result of ‘‘likely
progression”.
In this paper, we propose an approach for glaucoma change
detection using an optimization framework (abbreviated CDOF).
This approach is based on learning from a population of glaucoma
data and can be applied to visual fields for detecting glaucomatous
progression with the capability of providing an estimate of the rate
of progression. Our method was designed to be robust, in that it
can be applied to estimate the rate of change in any multidimen-
sional data, including structural imaging tests. We will show that
the proposed framework requires only longitudinal data for train-
ing compared to our previously proposed machine learning-based
models, VIM and GEM, that require both cross-sectional and longi-
tudinal data [17,21]. We then demonstrate that the proposed
framework is algorithmically and computationally less complex
than VIM and GEM.
Table 1 provides a comparison between the different glaucoma
progression detection methods described above. The information
provided in the table follows:
(1) Is the method trend- or event-based? Trend-based methods
typically rely on linear regression of an independent vari-
able, and theoretically two visits are enough to detect
change based on these methods; however, in practice far
more than two visits are necessary for these methods to pro-
vide a robust estimation, due to longitudinal test–retest
variability [22].
(2) Does the method make use of individual or population-
based data? Some of the population-based methods need a
large group of subjects and an environment for detecting
change (e.g., methods five through eight). GPA, PLR, and
PoPLR methods do not require any additional information
other than longitudinal visual fields of the test eye to detect
progression or glaucoma-related change. These individual-
Table 1
Comparison of different glaucoma progression detection methods.
Method Trend- or event-based Individualized or population-based Local or global analysis Provides rate of change
OLSR of MD Trend-based Population-based Global analysis Yes
OLSR of VFI Trend-based Population-based Global analysis Yes
PLR Trend-based Individualized Local analysis No
PoPLR Trend-based Individualized Local analysis No
ANSWERS Trend-based Population-based Local analysis No
VIM Trend-based Population-based Local analysis No
GEM Trend-based Population-based Local analysis No
CDOF Trend-based Population-based Local analysis Yes
GPA Event-based Individualized Local analysis No
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based methods because they don’t require analyzing a pop-
ulation of eyes for creating an environment (calculating
model parameters) for progression detection.
(3) Is the analysis based on global or local measurements? OLSR
of MD and VFI are considered global methods because MD
and VFI are global indices. Local methods either analyze each
individual visual field test location on a point by point basis,
e.g., GPA, PLR, and PoPLR; or they analyze a subset of visual
field test locations, e.g., ANSWERS, VIM, GEM and CDOF.
Local methods are theoretically more accurate than global
methods, because they allow the user to exclude uninforma-
tive test locations.
(4) Does the method provide rate-of-change information? Hav-
ing access to the progression rate offers eye specialists addi-
tional relevant information for disease management.
2. Method
2.1. Participants
Study participants were selected from two University of Califor-
nia at San Diego (UCSD)-based studies; the Diagnostic Innovations
in Glaucoma Study (DIGS) and the African Descent and Glaucoma
Evaluation Study (ADAGES, a multicenter study). Both studies
adhered to the tenets of the Declaration of Helsinki and to the
Health Insurance Portability and Accountability Act, and all partic-
ipants provided written informed consent. SAP testing was per-
formed using the 24-2 Swedish Interactive Thresholding
Algorithm (SITA), and unreliable tests (>33% fixation losses or
false-negative results or >15% false-positive results) were
excluded. Trained reviewers from the UCSD-based Visual Field
Assessment Center (VisFACt) assessed all visual field tests studied
for any apparent artifacts (e.g., lid or rim artifacts, signs of fatigue).2.2. Datasets
Two different longitudinal datasets were employed. The first
dataset included 91 eyes from 48 study participants with repeat-Table 2
Demographic information of study eyes.
Parameter Stable
Number of eyes 91
Number of subjects 48
Mean number of visual field follow-up (S.D.) 4.7 (0.8)
Months of follow-up (S.D.) 1.1 (0.2)
Age at baseline in years (S.D.) 70.9 (9.5)
Percent male 55
Baseline MD in dB (S.D.) 7.4 (8.2)
Baseline PSD in dB (S.D.) 6 (4.2)able glaucomatous SAP defects at baseline (defined as pattern stan-
dard deviation (PSD) 6 0.05 or a glaucoma hemifield test outside of
normal limits [23]). Each study eye was tested once a week for
about 5 weeks, resulting in the collection of 421 SAP visual field
measurements. Because glaucoma develops over years and not
weeks, we assumed any changes during this short follow-up dura-
tion likely would be due to noise and other sources of variability.
This dataset simulates stable eyes with glaucoma followed for
years, constitutes our control patients, and is called the stable
group.
The second dataset included 83 eyes from 74 study participants
with known progressive glaucomatous optic neuropathy that was
defined as an apparent decrease in the neuroretinal rim width, or
the appearance of a new or enlarged retinal nerve fiber layer defect
in paired longitudinal stereoscopic images by observers masked to
patient identification and diagnosis. This assessment was indepen-
dent of any visual field changes in the classification step to avoid
any bias in the evaluation of the proposed method that uses visual
field measurements to detect progression. A total of 1,161 SAP
visual field measurement visits were available from this group.
This dataset constitutes our progressed group. In Table 2 we have
provided the demographic information of the participants in the
stable and progressed groups. A decrease in MD indicates increased
disease severity; an increase in PSD corresponds to an increased
disease severity.2.3. Pipeline
Fig. 2 shows the entire pipeline for glaucoma change detection.
Step one includes visual field preprocessing to generate SAP fea-
ture vectors for the optimization framework. As shown in Fig. 3,
for each eye, we sort all longitudinal SAP data vectors in time
and we then compute the difference between each SAP data vector
and its follow-up. Doing so, we obtain a longitudinal time series of
feature vectors for each eye.
If the visual field abnormality (defined above) progresses over
time, then the magnitude of SAP feature vectors becomes increas-
ingly large. Therefore, in step two, the problem of detecting change
in the visual field of an eye over time can be framed as the problemProgressed by photo p-Value
83 –
74 –
14 (4.8) <0.01
109.2 (26.4) <0.01
62.5 (12.4) <0.01
48 0.18
4.4 (5.8) <0.01
5 (4.2) 0.12
Fig. 2. Pipeline for progression detection using optimization framework.
Fig. 3. Preprocessing: longitudinal SAP visual fields and feature vector creation.
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time. We seek a vector (direction) where the amount of change (for
all feature vectors fromprogressed eyes over time) along that vector
ismaximal. This can be formulated as an optimization framework to
find theoptimalvector (direction) fordetectingchange invisualfield
(loss) over time. Fig. 3 shows the process of feature vector creation
(i.e., preprocessing), schematically.
Essentially, step two is a combination of classification and opti-
mization. In this step, we first find the parameters of the optimiza-
tion framework based on the SAP feature vectors of 80% of the eyes
in the progressed group and then test the optimization framework
model against the remaining 20% of the eyes in the progressed
group (no overlap in training data, i.e., five-fold cross-validation).
We calculate the SAP feature vectors for all eyes in the training
subset. Mathematically, finding a vector (direction) in 52-
dimensional space that maximizes the likelihood of change detec-
tion is equivalent to minimizing the inner product of all SAP fea-
ture vectors (calculated from visual fields in the training group)
and the objective vector (direction).
This vector (direction) constitutes the objective function of the
optimization framework. The optimization framework is solved on
a unit hypersphere (isoseverity surface) because we seek only the
direction of the objective vector and not its magnitude (glaucoma
severity).
Hence, we can formulate the problem of finding the optimal
direction for detecting change as:minimize
Xn
i¼1
qTi x
subject to xTPx 1 ¼ 0
ð1Þwhere x is the objective vector (direction, of size 52  1), qi is a SAP
feature vector coefficient (size 52  1) (difference of visual fields at
tj and tj+1), n is the number of feature vector coefficients (number of
all SAP feature vectors from all eyes in the training group), P is the
identity matrix of size 52  52, and 1 and 0 are scalar values. The
constraint forces the objective vector x to terminate on the surface
of the unit hypersphere. This framework is convex because the
objective function is linear and the equality constraint has a quad-
ratic form [24]. Therefore, we minimize a linear objective function
over a convex set, a hypersphere including the feasible set of vec-
tors. More specifically, this framework is a quadratically con-
strained quadratic program (QCQP) [24] and has a global
minimum that can be solved efficiently using convex optimization
solvers. Solving the optimization framework above provides us
the optimal vector or direction for analyzing glaucoma change in
the original SAP visual field space.
The optimization framework was trained five times on the
training data, each time excluding one of the partitions for testing.
Therefore, we computed five different objective vectors based on
five different training datasets. We used CVX, the Matlab software
for disciplined convex programming for constructing and solving
Fig. 4. Glaucoma boundary limit specification. Projecting the visual field data
vectors on the objective vector x and estimating the slope using linear regression. P0
to P5 indicate six longitudinal visual field data vectors for an eye. S0 to S5 indicate
the projected values on the objective vector x.
Fig. 5. Distribution of the linear regression slopes of the projected visual fields data
vectors of all eyes in the stable group on the objective vector x. The blue line
indicates the left tail 95th percentile. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
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results in the objective vector x, and analyzing the visual fields
across that vector maximizes the likelihood of detecting change
(progression).
In step three, we calculate the glaucoma boundary limits as
shown in Fig. 4. To this purpose, we use the stable dataset (where
each eye has 5 visits over a short duration). First, to simulate a
stable eye with 10 visits, SAP longitudinal data vectors of each
eye in the stable dataset were randomly resampled 1000 times
with replacement using the bootstrap method, to mimic the aver-
age number of visits in the eyes from the progressed dataset. The
longitudinal sequence of visual field data vectors of each stable
eye were projected onto the identified objective vector x and the
rate of progression of each visual field data vector was calculated
using linear regression as shown in Fig. 4.
Then the 95th percentiles towards the direction of deterioration
for objective vector x was calculated from the histogram of the
slopes. Because eyes in the stable group presumably showed no dis-
ease related progression, the variability in this group was used to
define the progression limits. This procedure was repeated five
times (for five-folds), each time using the identified objective vec-
tor x for that fold. The outcome of the glaucoma boundary determi-
nation step is five glaucoma boundaries (95th percentiles) for each
classification fold.
Step four is the progression detection step. We used the pre-
viously described Progression of Patterns (POP) [17] along objec-
tive vector x for detecting change (progression). Specifically, each
visit (among a series of longitudinal visual field data vectors) of
each eye in the test fold of the progressed group was projected
onto the objective vector x, corresponding to its training fold.
The rate of progression (slope) of the longitudinal sequence of
visual field data vectors along the objective vector x was esti-
mated using linear regression. The test eye was classified as pro-
gressed when the rate of progression exceeded the 95th
percentile progression limit developed on the eyes with simu-
lated stability; otherwise, the eye was classified as non-
progressed.
To compare our method against linear regression of MD and VFI,
a similar procedure was performed to define the limits of stability
to detect progression using those global metrics. For PLR and
PoPLR, we followed the same procedure as previously described
[8,9].3. Results and discussion
Fig. 5 shows the distribution of the slopes of the projection
magnitudes of all visual field data vectors in the stable group along
objective vector x (from one fold). The left tail of the 95th per-
centile limit is shown as a blue line. For a test eye, if its slope
exceeded this limit, the eye was classified as progressed.
Fig. 6 shows progression detection in two example eyes. The
orange circles represent the magnitude of the projected visual field
data vector (severity) along objective vector x. The blue line indi-
cates the slope of the orange circles approximated using a linear
regression. The gray line indicates the glaucoma boundary limit
across the objective vector x (95th percentile of the stable eyes
across that vector). If the estimated slope falls below the gray line
(progression zone), then the eye is classified as progressed; other-
wise, the eye is classified as non-progressed. Therefore, the study
eye in Fig. 6 (left panel) is detected as progressed and the study
eye in Fig. 6 (right panel) is detected as non-progressed. The rate
of progression is shown graphically. Visual field loss of the eye in
the left panel is faster than the eye in the right panel.
Table 3 shows the progression detection sensitivities of CDOF,
VIM, GEM, PoPLR, PLR, linear regression of MD, and linear regres-
sion of VFI at various specificities. Because we used two indepen-
dent datasets in our analysis to define glaucoma boundary limits
and to detect progression, we were unable to obtain continuous
specificity and sensitivity for PoPLR and PLR. Therefore, we have
listed sensitivity and specificity trade-offs at eight discrete points
along the ROC curve shown in Fig. 7.
Fig. 7 shows the ROC curves between 85% and 100% specificities
for CDOF, VIM, GEM, linear regression of MD and linear regression
of VFI and the discrete sensitivity–specificity responses of PoPLR
and PLR methods. It can be observed that the performance of CDOF,
VIM, GEM, PoPLR, and PLR are similar and are significantly better
than linear regression of MD and linear regression of VFI. At higher
specificities, CDOF slightly outperforms VIM, GEM, PoPLR and PLR
methods however, as Table 3 shows, differences are not statisti-
cally significant.
To employ our algorithm in a clinical setting, we will identify
the objective vector x from all data in the progressed group, com-
pute the glaucoma boundary limits and save all of the parameters.
Clinicians and researchers will be able to feed the longitudinal
Fig. 6. Progression detection by the proposed optimization framework in two sample eyes. The gray line indicates the 95th percentile limit. The orange circles represent the
actual projected visual field values on objective vector x, and the blue circles are linear regression approximations of the orange circles. The eye in the left panel is classified as
progressed and the eye in the right panel is classified as non-progressed.
Table 3
Progression detection sensitivities (and corresponding confidence intervals) of CDOF, VIM, GEM, PLR, PoPLR, MD and VFI at various specificities (Bold values indicate best
performing method at each listed specificity).
Specificity (%) Sensitivity [confidence interval]
CDOF VIM GEM PoPLR PLR MD VFI
100 8.7 [1.4,14] 2.4 [0.0,5.8] 4.8 [0.0,9.2] 6.1 [0.0,10.8] – 0 [0.0,1.0] 0 [0.0,0.6]
99 40.0 [24.3,46.1] 26.5 [13.6,33.0] 30.1 [16.4,36.6] 28.0 [14.8,34.5] 31.3 [17.3,37.7] 4.8 [0.0,9.0] 2.4 [0.0,5.8]
97 47.5 [30.6,53] 44.6 [28.1,50.3] 42.2 [26.1,48.1] 31.7 [17.6,38.2] – 15.4 [5.6,21.6] 8.3 [1.1,13.6]
96 50.0 [32.7,55.3] 47.0 [30.1,52.5] 43.4 [27.1,49.2] – 42.2 [26.1,48.1] 15.5 [5.6,21.6] 10.7 [2.5,16.3]
95 50.0 [32.6,55.2] 48.2 [31.1,53.6] 50.6 [33.2,55.8] 41.5 [25.5,47.4] 44.6 [28.1,50.3] 16.7 [6.4,22.9] 14.3 [4.8,20.3]
93 52.5 [34.8,57.5] 53.1 [35.3,58.0] 56.6 [38.5,61.6] 54.9 [36.9,59.6] – 22.6 [10.7,29.1] 21.4 [9.8,27.8]
89 58.7 [40.3,63.5] 55.4 [37.3,60.1] 59.0 [40.6,63.3] 61.0 [42.3,65.0] – 32.1 [18.0,38.6] 29.8 [16.1,36.2]
87 61.2 [42.5,65.2] 59.0 [40.6,63.3] 60.2 [41.7,64.3] 63.4 [44.5,67.1] – 34.5 [19.9,40.9] 34.5 [19.8,40.9]
Fig. 7. Partial ROC curve showing sensitivity versus 1-specificity of CDOF, VIM,
GEM, PoPLR, PLR (based on two significant deteriorating locations), PLR (based on
three significant deteriorating locations), linear regression of MD and linear
regression VFI over time.
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the output as a binary class, i.e., progressed or not progressed. They
also will be able to observe the progression rate graphically.
From an algorithmic complexity perspective, progression detec-
tion using the optimization framework utilizes a sound mathemat-
ical framework with a single objective vector to create the
progression detection environment while our previously described
methods were two-step processes. Step one included unsupervised
machine learning on cross-sectional visual fields (a separate data-set of visual field tests at the baseline visit) to find the glaucoma-
associated clusters.
The glaucoma associated clusters were then decomposed into
several axes (to identify optimal directions of progression) using
independent or principal component analysis (step two). As can
be inferred, our previously unsupervised machine learning-based
approaches employ a more complex environment than the pro-
posed approach for progression detection.
To compare the computational complexity of CDOF to the
previous machine-learning-based approaches objectively, creat-
ing the progression detection environment using VIM [17] takes
approximately 168 h (7 days) in a quad-core machine (eight
gigabytes of memory), creating the GEM progression detection
environment [21] takes approximately 3 h, while creating the
proposed progression detection environment using the optimiza-
tion framework takes a fraction of a minute using a similar
machine. However, once the VIM and GEM progression detection
environments have been established and criteria for progression
detection have been defined, run-time is similar for VIM, GEM,
and CDOF methods. CDOF retains an advantage of being modifi-
able in less time, because of the markedly reduced development
time.
Comparing the computational complexity of all methods in
order, linear regression of MD involves a single OLSR analysis
and linear regression of VFI involves a combination of weighing
the visual field points in conjunction with a single OLSR analysis.
Therefore, linear regression of MD is the least computationally
complex method followed by linear regression of VFI. CDOF
involves a combination of visual field projection and a single OLSR
analysis while VIM and GEM both involve a combination of visual
field projection and seven OLSR analyses. PLR involves fifty-two
OLSR analyses and PoPLR that involves fifty-two OLSR analyses
on all permutations of visual field exams is the most computation-
ally complex method.
102 S. Yousefi et al. / Journal of Biomedical Informatics 58 (2015) 96–103Because CDOF is computationally and algorithmically less com-
plex than previously described machine learning-based methods,
VIM and GEM, according to Occam’s razor principle [27], it is
preferable (however, see below).
One possible limitation of our approach is the generation of 10-
visit pseudo-longitudinal series from 5-visit visual field data in our
stable group, tested over several weeks. This does not account for
the effects of aging, glaucoma treatment, and long-term measure-
ment variability observable over years.
Another possible limitation is that CDOF results in a single opti-
mal direction for glaucoma progression, while we know the direc-
tion of progression is not limited to one. Even though this approach
uses a single vector, its performance is not less effective than our
previous approaches that used seven directions (VIM and GEM).
However, unlike VIM and GEM, CDOF does not provide information
about visible patterns of VF progression that could be useful to a
clinician who is interested in the location of VF is progression in
order to investigate the possibility of corresponding structural
change (as corroborating evidence of disease-related progression).
From the simplicity standpoint, approaches using linear regression
of global indices provide a simpler and faster framework than
other methods, with sensitivity for detecting known progression
is greatly compromised.
Finally, it is possible that we have underestimated the perfor-
mance of PoPLR. For PoPLR, at least seven independent exams are
ideal to generate a robust outcome. Our stable dataset, with a
mean of five exams, might affect the sensitivity of PoPLR, by
increasing variability. For a more accurate comparison, we suggest
using a dataset with at least seven longitudinal visual field exams.
This limitation does not affect the comparison of progression
detection performance of CDOF, VIM, GEM, PLR, MD, and VFI.4. Conclusion
The proposed optimization framework provides a low complex-
ity environment and is computationally more efficient than our
previous approaches. Moreover, progression detection using opti-
mization framework suggests a slightly higher sensitivity at higher
specificities than VIM, GEM, PLR, and PoPLR methods and is as sen-
sitive as VIM, GEM, PLR, and PoPLR at lower specificities. CDOF also
is significantly more sensitive than methods based on linear
regression of global indices provided by the standard instrument
software. The proposed framework has potential application in
glaucoma clinics for progression detection and could be applied
to other longitudinal healthcare data to detect measurement
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